Investor Perspective: How Can Partnering with Pharma Impact Startup Success?
It may be prudent for startup entrepreneurs to plan how and when to interact with pharma. There are many ways in which biotech start-ups can interact with pharma companies. Pharma might be a parent company for a spinout. They may be an early- or late-stage investor, or an acquisition partner. Alternatively or additionally, they may be a development partner with extensive knowledge and a network to tap into.
View this recording as a panel of investors share their views on collaborating and partnering with pharma companies. What do entrepreneurs need to consider in their partnering strategy? Which type of partnering fits at which stage? What are the opportunities and pitfalls? Join the Johnson & Johnson Innovation webinar as we explored potential success factors for biotech startups.